AstraZeneca Begins Trading on the New York Stock Exchange
February 03, 2026
February 03, 2026
WILMINGTON, Delaware, Feb. 3 -- AstraZeneca, a biopharmaceutical company, issued the following news release on Feb. 2, 2026:
* * *
AstraZeneca begins trading on the New York Stock Exchange
Ordinary shares now trade across the NYSE, LSE and STO under a harmonized global listing structure
*
AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to part . . .
* * *
AstraZeneca begins trading on the New York Stock Exchange
Ordinary shares now trade across the NYSE, LSE and STO under a harmonized global listing structure
*
AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to part . . .